Literature DB >> 10821456

Quality use of allopurinol in the elderly.

P Smith1, N Karlson, B R Nair.   

Abstract

Allupurinol is a commonly prescribed drug. However, the use of this drug is not based on evidence and guidelines. We audited Allopurinol prescriptions in patients aged 65 years and over in a teaching hospital over 22 weeks. In 47% of patients the dose was higher than recommended and in 40% it was lower. Quality use of medications is an important issue to maintain quality of life in the elderly.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821456     DOI: 10.1046/j.1440-1762.2000.00353.x

Source DB:  PubMed          Journal:  J Qual Clin Pract        ISSN: 1320-5455


  7 in total

Review 1.  Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?

Authors:  Ted R Mikuls; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

2.  Quality of care for gout in the US needs improvement.

Authors:  Jasvinder A Singh; James S Hodges; John P Toscano; Steven M Asch
Journal:  Arthritis Rheum       Date:  2007-06-15

Review 3.  Management of gout in general practice--a systematic review.

Authors:  Andrew Jeyaruban; Sarah Larkins; Muriel Soden
Journal:  Clin Rheumatol       Date:  2014-09-17       Impact factor: 2.980

Review 4.  Quality of life and quality of care for patients with gout.

Authors:  Jasvinder A Singh
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

5.  Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre.

Authors:  Annie Pierre Jonville-Béra; Hassan Saissi; Lamiae Bensouda-Grimaldi; Frederique Beau-Salinas; Haware Cissoko; Bruno Giraudeau; Elisabeth Autret-Leca
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 6.  Uricase and other novel agents for the management of patients with treatment-failure gout.

Authors:  John S Sundy; Michael S Hershfield
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

Review 7.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.